AstraZeneca has launched an online direct-to-consumer (DTC) medicine platform in the US, joining a growing list of companies ...

Lithuania is rapidly growing as a leading force in the European life sciences scene, with over 400 life sciences companies in ...

The 100% rate on imported, branded pharma products will not apply to drugmakers constructing manufacturing facilities in the ...

Mérieux Equity Partners has outlined its approach to investing in Lithuania and wider Europe, highlighting a particular focus ...

Synaffix has entered a licensing agreement with South Korean biopharmaceutical firm Qurient to develop a dual-payload ADC.

Lilly has received approval from the US Food and Drug Administration (FDA) for Inluriyo (imlunestrant) to treat advanced ...

Share price in Harmony tumbled in the wake of the Phase III trial miss, with a route to market for ZYN002 looking bleak.

Patients will now be able to access BMS' Sotyktu for significantly cheaper than current list prices, alongside BMS and Pfizer ...

Evaxion’s preclinical asset targets an unknown infectious disease in which there are no other vaccines available.

After demonstrating that its gene therapy can slash Huntington's disease progression by 75%, Uniqure will now file for ...

The contract replaces BARDA’s agreement with Venatorx, the company that licensed the oral antibiotic to Basilea.

Moderna has opened its new vaccine manufacturing and R&D facility in Oxfordshire, UK, the Moderna Innovation and Technology ...